Navigation Links
Co-sponsors highlight important research to be presented at the 2013 Breast Cancer Symposium
Date:9/6/2013

SAN FRANSISCO, CA Five additional studies of note are among those that will be presented at the 2013 Breast Cancer Symposium, taking place September 7-9, 2013 at the San Francisco Marriott Marquis in San Francisco, California. Two studies examine cognitive function in women who undergo treatment for early-stage breast cancer; a third evaluates impact of tumor genotyping on clinical trial enrollment; and the final two evaluate the outcomes of different treatment approaches.

Saturday, September 7 Presentations

Abstract #48:
Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcome.

General Poster Session A
Saturday, September 7, 2013, 11:30 AM 1:00 PM PST
Saturday, September 7, 2013, 4:30 PM 6:00 PM PST
Golden Gate Hall

Napa Parinyanitikul, MD
The University of Texas MD Anderson Cancer Center
Houston, TX

Abstract # 55:
Ten-year outcomes of accelerated partial breast irradiation compared with whole breast irradiation: A matched-pair analysis.

Poster Discussion A
Saturday, September 7, 2013, 4:00 PM 4:20 PM PST
Yerba Buena Ballroom, Salon 8

Jessica Wobb, MD
Oakland University William Beaumont School of
Medicine, Beaumont Cancer Institute
Royal Oak, MI

Sunday, September 8 Presentations

Abstract # 105:
Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.

Poster Discussion B
Sunday, September 8, 2013, 3:00 PM 3:20 PM PST
Yerba Buena Ballroom, Salon 8

Lara Heflin, PhD
New Mexico Highlands University
Las Vegas, NM

Abstract # 104:
Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.

Poster Discussion B
Sunday, September 8, 2013, 3:00 PM 3:20 PM PST
Yerba Buena Ballroom, Salon 8

Hope S. Rugo, MD
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Abstract # 145:
Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review.

Poster Discussion B
Sunday, September 8, 2013, 4:00 PM 4:20 PM PST
Yerba Buena Ballroom, Salon 8

Aditya Bardia, MD
Massachusetts General Hospital,
Harvard Medical School
Boston, MA


'/>"/>

Contact: Kate Blackburn
Kate.Blackburn@asco.org
571-483-1379
American Society of Clinical Oncology
Source:Eurekalert

Related medicine news :

1. PhUSE Co-sponsors the Annual FDA/PhUSE Computational Science Symposium, in Silver Spring Maryland, USA, March 18th-19th 2013
2. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
3. Scientific session and new research highlights
4. Triple negative breast cancer symposium highlights current advances
5. Study highlights need for coordination of care in stage 2 and 3 rectal cancer treatment
6. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
7. New influenza virus from seals highlights the risks of pandemic flu from animals
8. JAAOS study highlights success of nerve transfer surgery
9. Researchers highlight treatment, research needs for homeless families
10. Deadly outbreak of West Nile virus highlights urgent need for more research, funding
11. AAO-HNSF 2012 new oral research daily highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology: